trending Market Intelligence /marketintelligence/en/news-insights/trending/2fa13DWvJysOOmqzNIXisQ2 content esgSubNav
In This List

Alexion names CEO

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Alexion names CEO

Alexion Pharmaceuticals Inc. appointed Ludwig Hantson as its CEO.

Hantson, who also joins the Alexion board, is the former president and CEO of Baxalta Inc., a Baxter International Inc. spinoff. He succeeds David Brennan, Alexion's interim CEO.

Brennan will remain on Alexion's board of directors and is expected to be appointed the chairman of the company at the upcoming annual meeting May 10.